Patents Represented by Attorney Kent Barta
  • Patent number: 7544293
    Abstract: A unique valve assembly for simulated bed moving chromatography employs a combination of pressure compatible sealable materials that permit minimal frictional interaction between moving parts, ensures alignment of parts, and provides a method for conducting SMB countercurrent chromatography on a small scale, in which purity and separation efficiency are enhanced. Machine designs are disclosed which embody the SMB concepts. Finally, a quick disconnect connector and adaptor is provided for mounting chromatographic columns in an SMB device. Demonstration of this system in a fructose-glucose isomer separation with purity-recovery trade-off for this device is also presented.
    Type: Grant
    Filed: September 26, 2005
    Date of Patent: June 9, 2009
    Assignee: SEMBA Inc.
    Inventors: Anil Rajaram Oroskar, Saurabh Paresh Parikh, Asha Anil Oroskar, Kenneth U. Johnson, Anthony Joseph Escarcega
  • Patent number: 7449598
    Abstract: The present invention relates to methods for preparing lithium valproate and administering this compound to a subject in need of treatment with lithium and/or valproate. Pharmaceutical compositions are also provided that are useful therapies for the treatment of neurological, immunological, and viral-mediated disorders in warm-blooded mammals.
    Type: Grant
    Filed: March 19, 2007
    Date of Patent: November 11, 2008
    Assignee: BioLink Life Sciences, Inc.
    Inventors: Navdeep B. Malkar, Deanna Jean Nelson, Walter C. Holberg, III
  • Patent number: 5506105
    Abstract: In an in situ hybridization assay, cells are fixed under conditions which preserve essential morphology, followed by transcription-based nucleic acid amplification of intracellular mRNA targets. The amplified targets are visualized by hybridizing labelled probes to the target sequences. The assay thereby provides a convenient method for detecting specific gene expression associated with morphologic characteristics of diagnostic significance.
    Type: Grant
    Filed: March 22, 1994
    Date of Patent: April 9, 1996
    Assignee: Dade International Inc.
    Inventor: Paul V. Haydock
  • Patent number: 5395688
    Abstract: This invention provides a novel process of producing magnetically responsive fluorescent polymer particles comprising polymeric core particles coated evenly with a layer of polymer containing magnetically responsive metal oxide. A wide variety of polymeric particles with sizes ranging from 1 to 100 microns can be used a core particles and transformed into magnetically responsive polymer particles. The surface of these magnetically responsive polymer particles can be coated further with another layer of functionalized polymer. These magnetically responsive fluorescent polymer particles can be used for passive or covalent coupling of biological material such as antigens, antibodies, enzymes or DNA/RNA hybridization and used as solid phase for various types of immunoassays, DNA/RNA hybridization probes assays, affinity purification, cell separation and other medical, diagnostic, and industrial applications.
    Type: Grant
    Filed: August 30, 1993
    Date of Patent: March 7, 1995
    Assignee: Baxter Diagnostics Inc.
    Inventors: Chao-Huei J. Wang, Dinesh Q. Shah
  • Patent number: 5352773
    Abstract: The present invention relates to a stable hemoglobin based composition having sufficiently low levels of methemoglobin to effectively function as an oxygen carrying solution upon administration to a patient made by the process comprising: a) adding an oxygenated or deoxygenated form of said blood substitute to an oxygen impermeable package, and b) storing said container at from between 5.degree. C. to 45.degree. C. for sufficient time to permit the autoreduction of methemoglobin. The stable hemoglobin based composition includes hemoglobin, modified hemoglobin and/or encapsulated hemoglobin. To effectively function as an oxygen carrying solution upon administration to a patient, the stable hemoglobin based solution cannot have greater than about 50% of said hemoglobin based solution in the methemoglobin form but, preferably no more than about 15%. The invention further relates to a method to store a stable oxygen carrying solution according to the above discussed process.
    Type: Grant
    Filed: October 16, 1992
    Date of Patent: October 4, 1994
    Assignee: Baxter International Inc.
    Inventors: Richard L. Kandler, John C. Spicuzza
  • Patent number: 5334706
    Abstract: This invention provides a method to therapeutically increase perfusion in a mammal comprising administering stroma-free hemoglobin at a dose ranging from the least amount effective to increase perfusion, up to a dose of about 2500 mg per kilogram of body weight.
    Type: Grant
    Filed: January 30, 1992
    Date of Patent: August 2, 1994
    Assignee: Baxter International
    Inventor: Robert J. Przybelski
  • Patent number: 5310878
    Abstract: A biosynthetic cerebrospinal fluid control and method of use. Additionally, this invention relates to the isolation and purification of stable liquid human prealbumin, a component in the biosynthetic cerebrospinal fluid control.
    Type: Grant
    Filed: October 23, 1992
    Date of Patent: May 10, 1994
    Assignee: Baxter Diagnostics Inc.
    Inventor: Kathryn D. Herring
  • Patent number: 5283079
    Abstract: This invention provides a novel process of producing magnetically responsive fluorescent polymer particles comprising polymeric core particles coated evenly with a layer of polymer containing magnetically responsive metal oxide. A wide variety of polymeric particles with sizes ranging from 1 to 100 microns can be used a core particles and transformed into magnetically responsive polymer particles. The surface of these magnetically responsive polymer particles can be coated further with another layer of functionalized polymer. These magnetically responsive fluorescent polymer particles can be used for passive or covalent coupling of biological material such as antigens, antibodies, enzymes or DNA/RNA hybridization and used as solid phase for various types of immunoassays, DNA/RNA hybridization probes assays, affinity purification, cell separation and other medical, diagnostic, and industrial applications.
    Type: Grant
    Filed: December 14, 1989
    Date of Patent: February 1, 1994
    Assignee: Baxter Diagnostics Inc.
    Inventors: Chao-Huei J. Wang, Dinesh O. Shah
  • Patent number: 5266462
    Abstract: Methods are provided for measuring the procoagulant activity of platelets in blood by means of a chromogenic assay which is specific for procoagulant phospholipids. These methods include the determination of the resting activity and/or excitability of platelets, which determines the threshold at which activating clotting factors (circulating in blood) are dangerous. Also methods are provided for screening drugs for their potential inhibitory effect on the activation of platelets.
    Type: Grant
    Filed: June 3, 1992
    Date of Patent: November 30, 1993
    Assignee: Baxter Diagnostics Inc.
    Inventors: Hendrik C. Hemker, Robert J. Wagenvoord
  • Patent number: 5245038
    Abstract: A class of fluorescent rare earth chelates and the ligands upon which they are based whose molecular structure incorporates a plurality of substituted arylpyridine diacid units attached to a central template structure is disclosed. These ligands function as efficient energy transfer groups in fluorescent tagging reagents and tracers.
    Type: Grant
    Filed: March 27, 1991
    Date of Patent: September 14, 1993
    Assignee: Baxter Diagnostics Inc.
    Inventors: Ron L. Hale, Dennis W. Solas
  • Patent number: 5242806
    Abstract: A method and apparatus for assaying the sensitivity of biopsied tumor cells to chemotherapeutic agents using a predetermined amount of chemotherapeutic agent in an easily deliverable form is disclosed and claimed.
    Type: Grant
    Filed: May 15, 1992
    Date of Patent: September 7, 1993
    Assignee: Baxter Diagnostics Inc.
    Inventors: Yu P. Yen-Maguire, Tom Cox, Fred Lewis
  • Patent number: 5173434
    Abstract: A process to determine the concentration of any substance in a colorimetric, turbidimetric or nephelometric reaction using a fluorometric detector to measure fluorescence intensity. In particular, a change in color can be monitored by observing the measurement of fluorescence intensity of a fluorophore in an inert matrix. The absorption spectrum of the chromophore may overlap the excitation and/or emission spectrum of the fluorophore, thereby allowing the change in fluorescence to be related to the intensity of color in the reaction and thus related to the quantity of the substance of interest.
    Type: Grant
    Filed: November 5, 1990
    Date of Patent: December 22, 1992
    Assignee: Baxter Diagnostics Inc.
    Inventors: Roger J. Morris, Shoshana Bascomb, Carolyn S. Olson
  • Patent number: 5116989
    Abstract: A class of fluorescent rare earth chelates and the ligands upon which they are based whose molecular structure incorporates a plurality of substituted arylpyridine diacid units attached to a central template structure is disclosed. These ligands function as efficient energy transfer groups in fluorescent tagging reagents and tracers.
    Type: Grant
    Filed: May 30, 1989
    Date of Patent: May 26, 1992
    Assignee: Baxter Diagnostics Inc.
    Inventors: Ron L. Hale, Dennis W. Solas
  • Patent number: 5106957
    Abstract: A class of fluorescent rare earth chelates and the ligands upon which they are based whose molecular structure incorporates a plurality of substituted arylpyridine diacid units attached to a central template structure is disclosed. These ligands function as efficient energy transfer groups in fluorescent tagging reagents and tracers.
    Type: Grant
    Filed: March 27, 1991
    Date of Patent: April 21, 1992
    Assignee: Baxter Diagnostics Inc.
    Inventors: Ron L. Hale, Dennis W. Solas
  • Patent number: 5091206
    Abstract: This invention provides a novel process of producing magnetically responsive polymer particles comprising polymeric core particles coated evenly with a layer of polymer containing magnetically responsive metal oxide. A wide variety of polymeric particles with sizes ranging from 1 to 100 microns can be used a core particles and transformed into magnetically responsive polymer particles. The surface of these magnetically responsive polymer particles can be coated further with another layer of functionalized polymer. These magnetically responsive polymer particles can be used for passive or covalent coupling of biological material such as antigens, antibodies, enzymes of DNA/RNA hybridization and used as solid phase for various types of immunoassays, DNA/RNA hybridization probes assays, affinity purification, cell separation and other medical, diagnostic, and industrial applications.
    Type: Grant
    Filed: May 30, 1989
    Date of Patent: February 25, 1992
    Assignee: Baxter Diagnostics Inc.
    Inventors: Chao-Huei Wang, Dinesh O. Shah
  • Patent number: 5055578
    Abstract: A class of fluorescent rare earth chelates and the ligands upon which they are based whose molecular structure incorporates a plurality of substituted arylpyridine diacid units attached to a central template structure is disclosed. These ligands function as efficient energy transfer groups in fluorescent tagging reagents and tracers.
    Type: Grant
    Filed: November 5, 1990
    Date of Patent: October 8, 1991
    Assignee: Baxter Diagnostics Inc.
    Inventors: Ron L. Hale, Dennis W. Solas